The oligonucleotide therapeutics market is booming, projected to reach \$3784.6 million by 2025 and grow at a CAGR of 16%. Discover key drivers, trends, and leading companies shaping this rapidly expanding sector of genetic medicine, including treatments for neuromuscular diseases and ATTR amyloidosis.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
